The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Open accessAbstract
BACKGROUND: Although much is known about the natural history of systemic lupus erythematosus (SLE), the development of SLE autoantibodies before the diagnosis of the disease has not been extensively explored. We investigated the onset and progression of autoantibody development before the clinical diagnosis. METHODS: The Department of Defense Serum Repository contains approximately 30 million specimens prospectively collected from more than 5 million U.S. Armed Forces personnel. We evaluated serum samples obtained from 130 persons before they received a diagnosis of SLE, along with samples from matched controls. RESULTS: In 115 of the 130 patients with SLE (88 percent), at least one SLE autoantibody tested was present before the diagnosis (up to 9.4 years earlier; mean, 3.3 years). Antinuclear antibodies were present in 78 percent (at a dilution of 1:120 or more), anti-double-stranded DNA antibodies in 55 percent, anti-Ro antibodies in 47 percent, anti-La antibodies in 34 percent, anti-Sm antibodies in 32 percent, anti-nuclear ribonucleoprotein antibodies in 26 percent, and antiphospholipid antibodies in 18 percent. Antinuclear, antiphospholipid antibodies, anti-Ro, and anti-La antibodies were present earlier than anti-Sm and anti-nuclear ribonucleoprotein antibodies (a mean of 3.4 years before the diagnosis vs. 1.2 years, P=0.005). Anti-double-stranded DNA antibodies, with a mean onset 2.2 years before the diagnosis, were found later than antinuclear antibodies (P=0.06) and earlier than anti-nuclear ribonucleoprotein antibodies (P=0.005). For many patients, the earliest available serum sample was positive; therefore, these measures of the average time from the first positive antibody test to the diagnosis are underestimates of the time from the development of antibodies to the diagnosis. Of the 130 initial matched controls, 3.8 percent were positive for one or more autoantibodies. CONCLUSIONS: Autoantibodies are typically present many years before the diagnosis of SLE. Furthermore, the appearance of autoantibodies in patients with SLE tends to follow a predictable course, with a progressive accumulation of specific autoantibodies before the onset of SLE, while patients are still asymptomatic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,406
Statistical Methods for Survival Data Analysis.
Lachenbruch, P. A., & Lee, E. T. (1993) · Journal of the American Statistical Association · doi:10.2307/2290742 · Cited by 2,845
SYSTEMIC LUPUS ERYTHEMATOSUS: REVIEW OF THE LITERATURE AND CLINICAL ANALYSIS OF 138 CASES
HARVEY, A. M., SHULMAN, L. E., TUMULTY, P. A., CONLEY, C. L., & SCHOENRICH, E. H. (1954) · Medicine · doi:10.1097/00005792-195412000-00001 · Cited by 993
D'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Wallace, D. J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-436_2 · Cited by 658
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
Cited by
Items 101–120 of 120
Martinez-Berriotxoa, A., Ruiz-Irastorza, G., Egurbide, M.-V., Garmendia, M., Gabriel Erdozain, J., Villar, I., & Aguirre, C. (2007) · Lupus · doi:10.1177/0961203307083316 · Cited by 76
Chain, J. L., Alvarez, K., Mascaro-Blanco, A., Reim, S., Bentley, R., Hommer, R., Grant, P., Leckman, J. F., Kawikova, I., Williams, K., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00564 · Cited by 72
“It is well-established that autoantibodies can be elevated for months to years preceding the development of some reported autoimmune syndromes (77, 78), and it is known that autoantibodies can be found in normal unaffected populations due to infections and/or cross-reactivity of autoantibodies with microbial antigens…”
BackgroundCrispín, J. C., Apostolidis, S. A., Rosetti, F., Keszei, M., Wang, N., Terhorst, C., Mayadas, T. N., & Tsokos, G. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200143 · Cited by 64
Autoantibody diagnostics in clinical practice
Conrad, K., Roggenbuck, D., Reinhold, D., & Sack, U. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.014 · Cited by 64
A surge in anti-dsDNA titer predicts a severe lupus flare within six months
Pan, N., Amigues, I., Lyman, S., Duculan, R., Aziz, F., Crow, M., & Kirou, K. (2014) · Lupus · doi:10.1177/0961203313515763 · Cited by 59
Levine, J. S., Subang, R., Nasr, S. H., Fournier, S., Lajoie, G., Wither, J., & Rauch, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6504 · Cited by 51
Detection of autoantibodies using chemiluminescence technologies
Mahler, M., Bentow, C., Serra, J., & Fritzler, M. J. (2016) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1077461 · Cited by 47
Rekvig, O. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569234 · Cited by 42
(2011) · PubMed · Cited by 41
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies
GHIRARDELLO, A., VILLALTA, D., MOROZZI, G., AFELTRA, A., GALEAZZI, M., GERLI, R., MATHIEU, A., MERONI, P. L., MIGLIORINI, P., RADICE, A., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.045 · Cited by 35
Laboratory evaluation of anti-dsDNA antibodies.
Cockx, M., Van Hoovels, L., De Langhe, E., Lenaerts, J., Thevissen, K., Persy, B., Bonroy, C., Vercammen, M., & Bossuyt, X. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.12.029 · Cited by 30
Conrad, K., Ittenson, A., Reinhold, D., Fischer, R., Roggenbuck, D., Büttner, T., Bosselmann, H., Steinbach, J., & Schößler, W. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04801.x · Cited by 27
Fiegel, F., Buhl, A., Jaekel, H.-P., Werle, E., Schmolke, M., Ollert, M., & Luppa, P. (2010) · Lupus · doi:10.1177/0961203310369681 · Cited by 24
c-Rel gain in B cells drives germinal center reactions and autoantibody production
Kober-Hasslacher, M., Oh-Strauß, H., Kumar, D., Soberon, V., Diehl, C., Lech, M., Engleitner, T., Katab, E., Fernández-Sáiz, V., Piontek, G., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci124382 · Cited by 24
Stephens, C., Castiella, A., Gomez-Moreno, E. M., Otazua, P., López-Nevot, M.-Á., Zapata, E., Ortega-Alonso, A., Ruiz-Cabello, F., Medina-Cáliz, I., Robles-Díaz, M., et al. (2016) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000230 · Cited by 22
Comparison of current methods for anti‐dsDNA antibody detection and reshaping diagnostic strategies
Infantino, M., Palterer, B., Previtali, G., Alessio, M., Villalta, D., Carbone, T., Platzgummer, S., Paura, G., Castiglione, C., Fabris, M., et al. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13220 · Cited by 20
Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody
Kim, K. H., Han, J. Y., Kim, J. M., Lee, S. W., & Chung, W. T. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.010 · Cited by 19
Potential role of regulatory B cells in immunological diseases
Valizadeh, A., Sanaei, R., Rezaei, N., Azizi, G., Fekrvand, S., Aghamohammadi, A., & Yazdani, R. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.08.004 · Cited by 16
Sharmin, S., Ahmed, S., Saleh, A. A., Rahman, F., Choudhury, M., & Hassan, M. (2015) · Bangladesh Medical Research Council Bulletin · doi:10.3329/bmrcb.v40i2.25225 · Cited by 11
Evaluating the performance of four anti-dsDNA antibody detection methods
Gao, X., Wu, L., Li, Y., Wang, L., Huang, Z., Zhang, J., Su, Z., & Yang, B. (2025) · Lupus · doi:10.1177/09612033251371116 · Cited by 1
Metadata
- Authors
- Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-16
- Volume
- 349
- Issue
- 16
- Pages
- 1526-1533
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2078610240
- Cited by
- 2,578
- References
- 27
- FWCI
- 52.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.